← Leaderboards
Santanu Maitra
California State University Fresno
$758,395
Attributed
$758,395
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $239.5K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$758,395 · 1
By mechanism
R16$758,395 · 1
Top collaborators
No co-investigators on record.
Most similar at California State University Fresno
Same institution · by research overlap
- Mary Devereux Barakzai$375,686
- Jason Allan Bush$2,069,344
- Shirley A Kovacs$94,473
- Pilar De La Cruz-Reyes$104,262
Others in their field
Other Rising Stars on “Cell Line”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Jason Dickens · Duke University$12,259,409
- Meera Sampath · Suny At Binghamton$9,956,488
- Suma Babu · Massachusetts General Hospital$9,819,674
- Sabrina Paganoni · Massachusetts General Hospital$9,819,674
- Jinsy Andrews · Columbia University Health Sciences$9,819,674
Research focus
Cell LineAlzheimer&AposAffectAmyloidAmyloid FormationAmyloid PathologyAminesAgingApolipoprotein EApolipoprotein E-3Apolipoprotein E-4ApolipoproteinsAppendageAstrocytomaAtp Binding Cassette Transporter 1Atp-Binding Cassette TransportersAntagonistBiologicalBlood - Brain Barrier AnatomyBrainBrain CellCareerCarrier ProteinsChemical Synthesis
Grant awards (6)
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$139,897
R16 · FY2025 · GM · contact PI
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$139,471
R16 · FY2024 · GM · contact PI
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$100,000
R16 · FY2024 · GM · contact PI
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$139,779
R16 · FY2023 · GM · contact PI
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$99,548
R16 · FY2023 · GM · contact PI
Targeting AbcA1 and Ldlr production for the Discoveryof Alzheimer's disease Drugs$139,700
R16 · FY2022 · GM · contact PI